Procter & Gamble (PG) Cash & Equivalents (2009 - 2026)

Procter & Gamble (PG) has 18 years of Cash & Equivalents data on file, last reported at $12.3 billion in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 34.99% year-over-year to $12.3 billion in Q1 2026; TTM through Mar 2026 was $12.3 billion, a 34.99% increase from a year earlier, with the FY2025 full-year figure at $9.6 billion, up 0.78% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $12.3 billion, up from $10.8 billion in the prior quarter.
• Over the last five years, Cash & Equivalents for PG reached as high as $12.3 billion in Q1 2026 and fell as low as $6.7 billion in Q3 2022.
• Historically, Cash & Equivalents has averaged $9.1 billion across 5 years, with a median of $9.1 billion in 2025.
• Across the five-year window, Cash & Equivalents slumped 40.63% in 2022 and surged 45.05% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $6.9 billion in 2022, then advanced by 15.12% to $7.9 billion in 2023, then increased by 29.66% to $10.2 billion in 2024, then rose by 5.82% to $10.8 billion in 2025, then climbed by 13.68% to $12.3 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $12.3 billion in Q1 2026, $10.8 billion in Q4 2025, and $11.2 billion in Q3 2025.